Pulmonary artery enlargement predicts poor survival in patients with COPD: A meta-analysis


No previous meta-analysis has evaluated the relationship between pulmonary artery enlargement (PAE) measured by computed tomography (CT) and prognosis for patients with chronic obstructive pulmonary disease (COPD). Recently, several studies have suggested poor survival and reduced exercise capacity in COPD patients with PAE on CT scan, but there were conflicting results. We aimed to assess the prognostic value of PAE-CT in patients with COPD. Relevant studies were identified by searching major databases. Pooled outcomes were determined to assess the prognostic value of PAE-CT in COPD patients. Eighteen studies including 5694 participants were included. PAE indicated higher mortality in COPD patients (odds ratio [OR] = 3.06; 95% confidence interval [95% CI]: 1.76–5.32; p < 0.0001), shorter 6-minute walk distance (mean difference [MD] = −67.53 m; 95% CI: −85.98 to −49.08; p < 0.00001), higher pulmonary artery systolic pressure (MD = 15.65 mmHg; 95% CI: 13.20–18.11; p < 0.00001), longer length of hospital stay (MD = 2.92 days; 95% CI: 0.71–5.12; p = 0.009) and more severe symptom such as dyspnea (COPD Assessment Test MD = 3.14; 95% CI: 2.48–3.81; p < 0.00001). We also conducted a subgroup analysis regarding the lung function and blood gas analysis for a stable period and acute exacerbation of COPD patients. In conclusion, PAE is significantly associated with mortality, lower exercise tolerance, and poor quality of life in patients with COPD. PAE may serve as a novel imaging biomarker for risk stratification in patients with COPD in the future.

Read the full article online




Huaqiao Chen,Tingting Shu,Lu Wang,Lingzhi Yang,Changchun Hu,Shanshan Du,Huang Wei

Published in:

Pulmonary Circulation Vol 12: No 3 cover image

July 2022

Pulmonary Circulation Vol 12: No 3

View this journal

Related articles

[Evaluation of the indirect impact of the Sars-CoV-2 epidemic on primary and ambulatory care processes using synthetic quality measures and graphic representations.].

Authors: Di Martino M, D'Ovidio M, Alagna M, Balducci M, Cappai G, Lallo A, Fusco D, Davoli M Source: Recenti Prog Med

[Community acquired pneumoniae and chronic obstructive pulmonary disease: the RWE analysis of events that required hospitalizations, and healthcare integrated costs.].

Authors: Ronconi G, Dondi L, Calabria S, Piccinni C, Pedrini A, Dondi L, Dell'Anno I, Esposito I, Addesi A, Viale P, Martini N Source: Recenti Prog Med

Misuse of Respiratory Inhalers Among Hospitalized Patients in a Tertiary Health Care Hospital in Kabul.

Authors: Mushkani EA, Hamidy F, Ahmad T, Adelyar MA Source: Int J Chron Obstruct Pulmon Dis

Time to sputum conversion in patients with pulmonary tuberculosis: A score to estimate the infectious period.

Authors: Ramirez-Hidalgo M, Trujillano-Cabello J, Espluges-Vidal A, Reñé-Reñé M, Santín M, Sánchez-Montalvá A, Bernet-Sánchez A, Gros-Navés L, Falguera M Source: J Clin Tuberc Other Mycobact Dis

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI